Polyethylene glycol 3350 in occasional constipation: A one-week, randomized, placebo-controlled, double-blind trial

doi:10.4292/wjgpt.v7.i2.274

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 2

This Article

(410)

(405)

(0)

(9393)

(5)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Randomized Clinical Trial

World J Gastrointest Pharmacol Ther. May 6, 2016; 7(2): 274-282
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.274

Full Size Figure Download Figure

Figure 3 Average visual analog scale scores for daily diary entries of bowel movements of subjects receiving polyethylene glycol 3350 or placebo (PP population). Error bars represent standard deviations of mean. BM: Bowel movement; PEG: Polyethylene glycol; VAS: Visual analog scale.

Citation: McGraw T. Polyethylene glycol 3350 in occasional constipation: A one-week, randomized, placebo-controlled, double-blind trial. World J Gastrointest Pharmacol Ther 2016; 7(2): 274-282
URL: https://www.wjgnet.com/2150-5349/full/v7/i2/274.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v7.i2.274

McGraw T. Polyethylene glycol 3350 in occasional constipation: A one-week, randomized, placebo-controlled, double-blind trial. World J Gastrointest Pharmacol Ther 2016; 7(2): 274-282 [PMID: 27158544 DOI: 10.4292/wjgpt.v7.i2.274]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.